Heping Li

Sun Yat-sen University — China

Medicine · Health Sciences

22h-index1.6kcitations82works3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(22), Cancer Immunotherapy and Biomarkers(17), RNA modifications and cancer(13), MicroRNA in disease regulation(11), Cancer-related molecular mechanisms research(11)

Publications82 total

Correction: STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma
Cancer & Metabolism·2025Open Access
Exploring the mechanisms of thermal aggregation resistance egg white: CMC concentration-mediated modification of protein structure and formation of microgel particles
Food Hydrocolloids·2025· 5 cited
Retraction Notice to: MYB Proto-oncogene-like 1-TWIST1 Axis Promotes Growth and Metastasis of Hepatocellular Carcinoma Cells
Molecular Therapy Oncology·2024Open Access
<scp>PD</scp>‐1 blockade enhances the effect of targeted chemotherapy on locally advanced <scp>pMMR</scp>/<scp>MSS</scp> colorectal cancer
Cancer Medicine·2024· 7 citedOpen Access
Prevalence and influencing factors of malnutrition in stroke patients with bulbar paralysis: a cross-sectional study in China
Frontiers in Nutrition·2024· 2 citedOpen Access
Overexpression of TNFSF11 reduces GPX4 levels and increases sensitivity to ferroptosis inducers in lung adenocarcinoma
Journal of Translational Medicine·2024· 7 citedOpen Access
Successful immunotherapy with PD-1 Iinhibitor for advanced pancreatic cancer: report of two cases and review of literature
Anti-Cancer Drugs·2024· 5 cited
STEAP4 inhibits cisplatin-induced chemotherapy resistance through suppressing PI3K/AKT in hepatocellular carcinoma
Cancer & Metabolism·2023· 7 citedOpen Access
Molecular mechanisms of HCG18 in the sorafenib resistance of hepatocellular carcinoma
Anti-Cancer Drugs·2023· 1 cited
Elevated FAM134B expression induces radiation-sensitive in hepatocellular carcinoma
BMC Cancer·2023· 2 citedOpen Access
Table S5 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Table S5 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Table S6 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Data from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Table S3 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Figure S1-S17 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Table S1, Table S2, Table S4, Table S8, Table S10, Table S11 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Table S6 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Table S7 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
Table S3 from The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Binhui Xie(16), Bing Zhang(10), Jianting Long(9), Shiqiu Xiong(9), Guosheng Tan(9), Qiangsheng Dai(8), Jianyong Yang(8), Liangshuai Liu(6), Yuankang Xie(6), Xiaonong Wang(5), Rui‐Xi Hua(5), Hui Tang(5), Weihao Lin(4), Binsheng Fu(4), Baiyin Zhong(4), Ruifang Zeng(3), Bing Zhang(3), Yong Gu(3), Jianwen Huang(3), Tuck−Yun Cheang(3)